Register for free to listen to this article
Listen with Speechify
0:00
1:00
NANTES, France—The French National Research Agency has awarded TcLand Expression SA $550,000 in research funding for a companion diagnostic program in rheumatoid arthritis. TcLand Expression is collaborating with research groups led by Professor Pierre Miossec at Edouard Herriot Hospital in Lyon, France, and Professor Olivier Vittecoq and Dr. Thierry Lequerré at Rouen University Hospital to develop a blood-based diagnostic test to predict the response to biological agents in rheumatoid arthritis (RA). According to the research partners, RA, a severe chronic inflammatory disease, affects approximately 1 percent of the population worldwide.


 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Blue sinusoidal pulse lines are shown in light blue against a dark blue background, representing a heartbeat signal.

Getting to the heart of drug safety testing

High throughput optical scanning enhances cardiac ion channel analysis for safer drug development.
A blue and orange double-helix representing DNA is undergoing transcription with a large orange shape representing RNA polymerase against a blue background

Harnessing CRISPR-Cas9: Knocking out genes in myeloid cells

Explore the applications of CRISPR-Cas9 technology in therapeutic development for Alzheimer’s disease.
A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue